COMMUNIQUÉS West-GlobeNewswire

SOPHiA GENETICS to Announce Financial Results for First Quarter 2024 on May 7, 2024
23/04/2024
BOSTON and ROLLE, Switzerland, April 23, 2024 (GLOBE NEWSWIRE) -- SOPHiA GENETICS, a cloud-native software company and a leader in data-driven medicine, today announced it will release its financial results for the [...]
Survey: Physicians Turning to Locum Tenens to Improve Work Conditions, Relieve Burnout
23/04/2024
Many Would Return to Permanent Positions If Conditions Right DALLAS, April 23, 2024 (GLOBE NEWSWIRE) -- Physicians and advanced practice professionals are opting for the flexibility of temporary, “locum tenens” work in [...]
HealthSource of Ohio names Jody Prather, MD, as its President and CEO
23/04/2024
CINCINNATI, April 23, 2024 (GLOBE NEWSWIRE) -- HealthSource of Ohio announced today the appointment of Jody Prather, MD as its next President and Chief Executive Officer following an extensive, nationwide search process [...]
Epic Bio Presents New Data Highlighting Potential of EPI-321 for FSHD and Epigenetic Editing Platform Leadership at ASGCT Annual Meeting
23/04/2024
- Across robust slate of presentations, company highlights compelling new data and strong differentiation - SOUTH SAN FRANCISCO, Calif., April 23, 2024 (GLOBE NEWSWIRE) -- Epic Bio , a leading epigenetic editing company [...]
Visory Health Secures Women’s Business Enterprise National Council Certification for Third Consecutive Year
23/04/2024
The Florida-based, woman-owned business granting accessible, affordable prescriptions to underserved populations joins 18,000 other prestigious female-led companies after rigorous vetting ESTERO, Fla., April 23, 2024 ( [...]
Viemed Healthcare Announces Date and Time for Conference Call
23/04/2024
LAFAYETTE, La., April 23, 2024 (GLOBE NEWSWIRE) -- Viemed Healthcare, Inc. (the “ Company ” or “ Viemed ”) (NASDAQ:VMD), a national leader in respiratory care and technology-enabled home medical equipment services, [...]
NeurAxis Announces New Medical Policy Coverage in North Dakota
23/04/2024
CARMEL, Ind., April 23, 2024 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis,” or the “Company”) (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies addressing chronic and [...]
Mobile-health Network and Online Pharmacy, Lifepack, Sign Partnership Facilitating Cooperation in Singapore and Indonesia
23/04/2024
SINGAPORE, April 23, 2024 (GLOBE NEWSWIRE) -- Mobile-health Network Solutions (Nasdaq: MNDR) (“MaNaDr” or the “Company”), a pioneering Asia-Pacific (“APAC”) telehealth provider, has announced a strategic partnership [...]
ICU Medical Announces Time of First Quarter 2024 Earnings Conference Call
23/04/2024
SAN CLEMENTE, Calif., April 23, 2024 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq: ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced the time of its first quarter [...]
Tarsus Strengthens Financial Position and Refinances Existing Debt with $200 Million Non-dilutive Financing Commitment from Pharmakon
23/04/2024
IRVINE, Calif., April 23, 2024 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), whose mission is to focus on unmet needs and apply proven science and new technology to revolutionize treatment for [...]
STRATA Skin Sciences to Present at the Planet MicroCap Showcase: Vegas 2024
23/04/2024
HORSHAM, Pa., April 23, 2024 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (“STRATA” or the “Company”) (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing, and marketing innovative [...]
Artelo Biosciences Announces Publication of Peer-Reviewed Article Highlighting FABP7 as a Promising Novel Target in Cancer Therapy
23/04/2024
Provides Further Evidence of Multiple Opportunities for Development of the FABP Inhibitor Platform in Cancer & Other Serious Conditions SOLANA BEACH, Calif., April 23, 2024 (GLOBE NEWSWIRE) -- Artelo Biosciences, [...]
GeneDx Announces Partnership with Komodo Health to Expand Access to World’s Largest Rare Disease Dataset
23/04/2024
The Company will also participate in a World Orphan Drug Congress panel presentation highlighting the role of genomic sequencing in advancing precision medicine STAMFORD, Conn., April 23, 2024 (GLOBE NEWSWIRE) -- GeneDx [...]
PaxMedica Responds to Emergency Request for IV Suramin and Commits to Provide Immediate Access to PAX-101
23/04/2024
TARRYTOWN, New York, April 23, 2024 (GLOBE NEWSWIRE) -- via IBN – PaxMedica Inc. (Nasdaq: PXMD) (the “Company”), a leading biopharmaceutical company dedicated to advancing treatments for neurological disorders, expects [...]
Palisade Bio Enters into Strategic Collaboration with Strand Life Sciences to Advance Precision Medicine Approach
23/04/2024
– Collaboration grants Palisade Bio access to cutting-edge expertise and tools in bioinformatics – Partnership marks a significant value-driving milestone in Palisade Bio's mission to redefine UC treatment through [...]
Wave Life Sciences Announces Continued Momentum in GSK Collaboration and Advancements in siRNA and RNA Editing
23/04/2024
GSK has selected the first two programs to advance following achievement of target validation, marking transition to next phase of research collaboration; programs utilize Wave’s next generation GalNAc-siRNA format with [...]
Optimi Health and Kwantlen Polytechnic University Applied Genomics Centre Partner to Advance Mushroom Science and Research
23/04/2024
VANCOUVER, British Columbia, April 23, 2024 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN), a leading Health Canada licensed psychedelics pharmaceutical manufacturer, is thrilled to [...]
USDA Grants Amfora Exemption for Its Patented, Gene-Edited, Ultra-High Protein Soy, Accelerating Path to Market
23/04/2024
SAN FRANCISCO, April 23, 2024 (GLOBE NEWSWIRE) -- The U.S. Department of Agriculture’s Animal and Plant Health Inspection Service (APHIS) has granted Amfora, Inc. an exemption for its gene-edited, ultra-high protein [...]
Sania Therapeutics presents latest from AAV gene therapy platform at the American Society of Gene & Cell Therapy Annual Meeting
23/04/2024
Sania Therapeutics presents latest from AAV gene therapy platform at the American Society of Gene & Cell Therapy Annual Meeting Abstracts outline an approach which is highly translatable, efficacious at low doses [...]

Pages